TRPC6 and focal segmental glomerulosclerosis: A single case of SR-FSGS (Indian-South African), with an age of onset of 18 years, was reported to have a novel probably damaging mutation (NM_004621:c.485G>T) in the TRPC6 (Table 3) gene and achieved partial remission following second line of immunosuppressors [17].